Surrozen Inc is a biotechnology company focused on developing regenerative medicines to treat a range of diseases. The company was founded in 2016 by five leading scientists in the fields of regenerative medicine and developmental biology. Its headquarters are located in South San Francisco, California, USA.
Surrozen's main area of focus is on Wnt signaling pathways, which play a crucial role in tissue regeneration and repair. By harnessing the power of Wnt signaling, the company aims to develop therapies that can stimulate tissue regeneration and healing in various diseases and conditions.
The company's technology platform allows them to identify and develop novel antibodies that target and modulate Wnt signaling, either activating or inhibiting it as needed. This approach holds significant potential for treating a wide range of degenerative diseases and conditions.
Surrozen's work has generated considerable interest in the biotechnology and regenerative medicine sectors, and they continue to collaborate with leading academic institutions and biopharmaceutical companies to advance their pipeline of potential therapies. Their goal is to bring innovative regenerative medicines to patients in need and make a significant impact on human health and well-being.